Bioavailability of Hesperidine and Narirutin From Orange Juice to Identify Metabotypes in Hypertension
NCT ID: NCT04234100
Last Updated: 2022-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
67 participants
INTERVENTIONAL
2020-02-24
2020-09-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
On this basis, the following hypothesis is presented: individuals with arterial hypertension can be classified into 3 different metabotypes that are the result of the ability to absorb hesperidin and narirutin, determined by the urinary excretion of their respective metabolites, and these metabotypes are associated with different microbiota enterotypes and with different fecal α-L-rhamnosidase activity.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of the Bioavailability of Three Hesperidin Extracts.
NCT03984916
Beneficial Impact of Orange Juice Consumption on Risk Factors Associated With Cardiovascular Diseases
NCT02479568
Orange Juice, Hesperidin and Their Role in Vascular Health Benefit
NCT04731987
Effect of Antioxidant Supplementation on the Autonomic Balance
NCT03510221
Bioavailability of Carotenoids From Orange Juice in a Cross-over Study in Healthy Subjects.
NCT04744233
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Orange juice rich in hesperidin and narirutin
The consumption of the orange juice will be made in a single dose of 500 ml. The juice is presented in a concentrated and frozen format, packed in opaque cans of 500 mL, for which it must be thawed and diluted with mineral water up to 1.5 L before its ingestion.
Orange juice rich in hesperidin and narirutin
The product is a concentrated orange juice provided by the CITRUS Department of Florida (USA: www.FloridaCitrus.org).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Orange juice rich in hesperidin and narirutin
The product is a concentrated orange juice provided by the CITRUS Department of Florida (USA: www.FloridaCitrus.org).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Systolic blood pressure ≤159 mm Hg
3. Sign the informed consent
Exclusion Criteria
2. Glucose \> 126 mg / dL
3. Systolic blood pressure ≥ 160 mm Hg and diastolic blood pressure \> 100 mm Hg or taking antihypertensive drugs
4. LDL cholesterol \> 189 mg / dL
5. Triglycerides \> 350 mg / dL
6. Anemia (hemoglobin ≤ 13 g / dL in men and ≤ 12 g / dL in women)
7. Tobacco addiction
8. Consumption of medicines, antioxidants or vitamin supplements 30 days before the study
9. Use of antibiotics during the last 30 days prior to the study
10. Consumption of prebiotics and / or probiotics during the 30 days prior to the study
11. Clinical history of gastrointestinal disease or presence of intestinal disorders at the time of inclusion
12. Chronic alcoholism
13. Monitoring a vegetarian diet
14. Pregnant or with intent to get pregnant
15. Being in breastfeeding period
16. Participation in a clinical trial or nutritional intervention study, in the last 30 days.
17. Inability to follow the study guidelines
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Technological Centre of Nutrition and Health, Spain
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rosa Solà, Dr
Role: PRINCIPAL_INVESTIGATOR
UTNS(Eurecat_Reus)/HUSJR. Reus, Tarragona, Spain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centro Tecnológico de Nutrición y Salud (Eurecat-Reus)
Reus, Tarragona, Spain
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Technological Centre of Nutrition and Health. Eurecat\_Reus
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FLAVOTIP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.